Target intelligence / Profile preview

Calcium-activated potassium channel subunit alpha-1 (SLO-1) (SLO-1)

Target
SLO-1
Molecular classification
Ion channel, Calcium-activated potassium channel, Potassium channel
01

Overview

The nematode SLO-1 calcium-activated potassium channel is a large-conductance (BK) ion channel that plays a critical role in modulating neuromuscular activity (Guest et al., 2007, PMID: 17947313). It is primarily expressed in the neurons and muscles of nematodes, where it regulates the release of neurotransmitters and controls muscle contraction (Crisford et al., 2011, PMID: 21435179). The channel opens in response to increases in intracellular calcium concentrations and membrane depolarization, facilitating potassium efflux and subsequent membrane hyperpolarization (Welz et al., 2011, PMID: 21245134). This physiological process is vital for the coordination of locomotion, feeding, and egg-laying in worms like Caenorhabditis elegans and various parasitic species (UniProt, P41929). SLO-1 is the principal molecular target for the anthelmintic drug emodepside, which binds to the channel and acts as a potent activator (Guest et al., 2007). Drug-induced activation of SLO-1 causes persistent hyperpolarization, leading to flaccid paralysis of the nematode's pharyngeal and body wall muscles (Crisford et al., 2011). This paralysis prevents the parasite from feeding and maintaining its position within the host, eventually resulting in its death. While SLO-1 has a human ortholog known as KCNMA1, emodepside shows high selectivity for the nematode version, making it a valuable therapeutic target with minimal host toxicity (Welz et al., 2011).

Other names
BK channelSlowpoke-1Large-conductance calcium-activated potassium channelslo-1KCNMA1 nematode ortholog
02

Mechanism of action

Agonist/Activator

03

Biological functions

Neuromuscular transmissionLocomotionNeurotransmitter release regulationMuscle contractionEgg-laying regulation
04

Disease associations

NematodiasisHelminthiasisParasitic infection
05

Safety considerations

Selectivity over human KCNMA1 (BK) channelsPotential for host neurotoxicity if selectivity is lost
06

Interacting drugs

Emodepside

1 more in the full profile.

07

Biomarkers

slo-1 gene mutations (anthelmintic resistance marker)

Beyond the preview

Go deeper on Calcium-activated potassium channel subunit alpha-1 (SLO-1) (SLO-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium-activated potassium channel subunit alpha-1 (SLO-1) (SLO-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call